Methocarbamol 850 mg Every Eight Hours Dosing
No, you cannot prescribe methocarbamol 850 mg every eight hours because this dose does not exist as a commercially available formulation, and the proposed regimen would deliver only 2.55 grams daily, which falls significantly below the FDA-recommended initial dosage of 6 grams daily for the first 48-72 hours. 1
FDA-Approved Dosing Regimens
The FDA label specifies two standard formulations and their corresponding dosing schedules 1:
For 500 mg tablets:
- Initial dosage: 3 tablets four times daily (6 grams/day)
- Maintenance dosage: 2 tablets four times daily (4 grams/day)
For 750 mg tablets:
- Initial dosage: 2 tablets four times daily (6 grams/day)
- Maintenance dosage: 1 tablet every 4 hours OR 2 tablets three times daily (4-4.5 grams/day)
Why 850 mg Every 8 Hours Is Problematic
Dosing inadequacy: The proposed 850 mg every 8 hours regimen would provide only 2.55 grams daily, which is less than half the FDA-recommended initial dose of 6 grams daily and well below the 4 gram maintenance dose 1.
Non-standard formulation: Methocarbamol is manufactured only as 500 mg and 750 mg tablets; an 850 mg dose would require splitting or combining tablets in non-standard ways 1.
Subtherapeutic dosing interval: The eight-hour interval (three times daily) contradicts the FDA's specified four-times-daily or every-four-hours dosing for optimal therapeutic effect 1.
Correct Prescribing Approach
For acute severe muscle spasm:
- Use 750 mg tablets: 2 tablets four times daily (6 grams/day) for 48-72 hours
- For very severe conditions: up to 8 grams daily may be administered 1
For maintenance therapy:
- Reduce to approximately 4 grams daily after initial 48-72 hours
- Use either 750 mg every 4 hours OR 1500 mg (two 750 mg tablets) three times daily 1
Special Populations and Safety Considerations
Renal impairment: Methocarbamol pharmacokinetics remain unchanged in patients with end-stage renal disease requiring hemodialysis, with similar elimination half-lives (1.24 hours in dialysis patients vs. 1.14 hours in healthy volunteers) and no dose adjustment required 2.
Alcohol interaction: Avoid concurrent alcohol use, as the combination of methocarbamol and ethanol can cause fatal central nervous system depression due to interactive sedative-hypnotic properties 3.
Intravenous formulation concerns: If considering IV methocarbamol, be aware of theoretical polyethylene glycol (PEG) toxicity concerns, though objective data supporting PEG-associated metabolic acidosis and nephrotoxicity remain lacking 4.
Common Prescribing Pitfalls
- Underdosing at initiation: Starting with maintenance doses (4 grams/day) instead of the recommended 6-8 grams/day for the first 48-72 hours reduces therapeutic efficacy 1
- Creating non-standard doses: Attempting to prescribe doses like 850 mg that require tablet manipulation increases medication errors
- Premature dose reduction: Reducing below 4 grams daily before adequate symptom control may result in treatment failure 1